Tired of out-of-memory errors derailing your data analysis? There's a better way to handle huge arrays in Python.

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...